Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Index investing focuses on steady, broad exposure to markets, helping you grow wealth over the long run with reduced complexity and lower costs.
27,799 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
The UFO ETF surged on Virgin Galactic strength, but a heavy tilt toward a single stock raises concentration concerns....
A universal technical institute director recently sold 10,000 shares, sparking questions about what it means for UTI ...
Perplexity's CEO argues that embracing the risk of idea theft keeps a fast-moving AI startup on its toes. The comment...
When a venerable logistics giant trades near the $120 mark, investors debate more than price. This guide weighs the u...
Nu Holdings stands at a pivotal moment in 2026. This piece breaks down three catalysts that could send Nu stock soari...
Crypto.com cuts around staff by about 12%, eliminating roughly 180 roles as it refocuses on AI-enabled enterprise ser...
Original Medicare continues to exclude routine dental care, leaving retirees to navigate costly implants, crowns and ...
Lands' End is at a crossroads as it approaches 2025 earnings. This guide breaks down what to watch, how to model pote...
Anthropic alleges Alibaba exploited thousands of fake accounts to copy AI outputs, prompting a swift stock reaction a...
When you hear an insider just sold 10,000 shares, it triggers questions. This guide explains how to interpret such mo...
Apple raises hardware prices by up to 20% amid memory-cost pressures, while Amazon’s AWS sees robust cloud demand. Th...